| Dr Roger Clay Vanarsdell, MD | |
|
275 Canterbury Way, Hendersonville, NC 28792 | |
| (828) 681-1839 | |
| Not Available |
| Full Name | Dr Roger Clay Vanarsdell |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 275 Canterbury Way, Hendersonville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083818082 | NPI | - | NPPES |
| 8911830 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 95-01138 (North Carolina) | Primary |
| Entity Name | Transylvania Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174549208 PECOS PAC ID: 4880592427 Enrollment ID: O20031222000135 |
News Archive
Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
Researchers in the UK have demonstrated the potential of modulating the expression of angiotensin-converting enzyme 2 (ACE2) as a novel host-directed therapeutic approach to protecting against coronavirus disease 2019 (COVID-19).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to its infrequent dosing and positive efficacy, nearly 90 percent of surveyed neurologists indicate they will prescribe Merck Serono/EMD Serono's oral cladribine for the treatment of multiple sclerosis.
› Verified 3 days ago
| Entity Name | Angel Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497753651 PECOS PAC ID: 9638253297 Enrollment ID: O20090312000353 |
News Archive
Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
Researchers in the UK have demonstrated the potential of modulating the expression of angiotensin-converting enzyme 2 (ACE2) as a novel host-directed therapeutic approach to protecting against coronavirus disease 2019 (COVID-19).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to its infrequent dosing and positive efficacy, nearly 90 percent of surveyed neurologists indicate they will prescribe Merck Serono/EMD Serono's oral cladribine for the treatment of multiple sclerosis.
› Verified 3 days ago
| Entity Name | Riverside Emergency Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306271119 PECOS PAC ID: 1153221692 Enrollment ID: O20140113000338 |
News Archive
Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
Researchers in the UK have demonstrated the potential of modulating the expression of angiotensin-converting enzyme 2 (ACE2) as a novel host-directed therapeutic approach to protecting against coronavirus disease 2019 (COVID-19).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to its infrequent dosing and positive efficacy, nearly 90 percent of surveyed neurologists indicate they will prescribe Merck Serono/EMD Serono's oral cladribine for the treatment of multiple sclerosis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roger Clay Vanarsdell, MD Po Box 217, Naples, NC 28760-0217 Ph: (828) 681-1839 | Dr Roger Clay Vanarsdell, MD 275 Canterbury Way, Hendersonville, NC 28792 Ph: (828) 681-1839 |
News Archive
Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
Researchers in the UK have demonstrated the potential of modulating the expression of angiotensin-converting enzyme 2 (ACE2) as a novel host-directed therapeutic approach to protecting against coronavirus disease 2019 (COVID-19).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to its infrequent dosing and positive efficacy, nearly 90 percent of surveyed neurologists indicate they will prescribe Merck Serono/EMD Serono's oral cladribine for the treatment of multiple sclerosis.
› Verified 3 days ago
Dr. Mark Robinson Chandler, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Justice St, Hendersonville, NC 28791 Phone: 828-696-1000 Fax: 828-696-1314 | |
Robert J. Bryant, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 212 Thompson St Ste A, Hendersonville, NC 28792 Phone: 828-697-3232 Fax: 828-698-0125 | |
Gary R Whitaker, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 212 Thompson St Ste A, Hendersonville, NC 28792 Phone: 828-697-3232 | |
Gabriela Ursin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Justice St, Hendersonville, NC 28791 Phone: 828-696-1000 Fax: 828-696-1314 | |
Clinton W Hamrick, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 212a Thompson St, Hendersonville, NC 28792 Phone: 828-697-3232 Fax: 828-698-0125 | |
Dr. Serena Famatta York, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Justice St, Hendersonville, NC 28791 Phone: 828-696-1000 Fax: 828-696-1314 |